Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022008149 - SATRAPLATIN FOR USE IN THE TREATMENT OF LYMPHOID NEOPLASMS

Publication Number WO/2022/008149
Publication Date 13.01.2022
International Application No. PCT/EP2021/065313
International Filing Date 08.06.2021
IPC
A61K 31/282 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
28Compounds containing heavy metals
282Platinum compounds
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61K 45/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants
  • DAYTON THERAPEUTICS AG [CH]/[CH]
Inventors
  • RENNER, Christoph Robert
  • ZANDER, Thilo Joachim
  • MARKSON, Gabriel Benjamin
  • DAHM, Felix
Agents
  • HGF
Priority Data
20184760.508.07.2020EP
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SATRAPLATIN FOR USE IN THE TREATMENT OF LYMPHOID NEOPLASMS
(FR) SATRAPLATINE POUR UTILISATION DANS LE TRAITEMENT DE NÉOPLASIES LYMPHOÏDES
Abstract
(EN) The present invention relates to satraplatin for use in a method of treating a malignancy of the lymphoid tissue in a mammal, preferably a human, and in particular of a malignancy of the lymphoid tissue with primary or secondary central nervous system (CNS) manifestation such as primary diffuse large B cell lymphoma of the CNS.
(FR) La présente invention concerne la satraplatine pour utilisation dans un procédé de traitement d’une tumeur maligne du tissu lymphoïde chez un mammifère, de préférence un humain, et en particulier une tumeur maligne du tissu lymphoïde avec une manifestation au niveau du système nerveux central (SNC) primaire ou secondaire telle que le lymphome diffus à grandes cellules B primitif du SNC.
Latest bibliographic data on file with the International Bureau